Biographical summary
Saravut J. Weroha, M.D., Ph.D., is a medical oncologist focusing primarily on gynecologic malignancies and phase 1 clinical trials. His specific areas of clinical focus include:
- Personalized cancer therapy using ovarian cancer patient-derived xenografts (PDXs), also known as Cancer Avatars, to accurately predict response to anti-cancer treatment.
- Implementing a multidisciplinary approach to cancer care for strategic utilization of anticancer therapies, such as surgery, radiation, ablation, embolization, and chemotherapy.
- Searching for molecular targeted therapies based on the specific genetic aberrations found within individual tumors by state-of-the-art next-generation sequencing techniques.
- Selection of clinical trials that fit the patient's tumor type, molecular profile, and goals of care. This requires careful consideration of individual social factors as well as tumor biology.
- Above all, working closely with patients as a guide to devise a therapeutic plan which is most optimal for the needs of our patients.
Dr. Weroha works to bridge the gap between promising new therapies in the laboratory and ultimately FDA approval of new therapies for patients with cancer.
Conditions treated
Interests
- Gynecologic oncology
- Animal surrogates of human tumors (avatars)
Mayo Clinic locations
Education
- 2013
Fellow - Medical Oncology, Clinical Investigator ProgramMayo School of Graduate Medical Education, Mayo Clinic College of Medicine
- 2010
Internship/Residency - Internal Medicine, Clinical Investigator ProgramMayo School of Graduate Medical Education, Mayo Clinic College of Medicine
- 2007
MDUniversity of Kansas School of Medicine
- 2007
PhD - Pharmacology, Toxicology and TherapeuticsUniversity of Kansas School of Medicine
- 1998
BS - Cellular Biology, with Honors and DistinctionUniversity of Kansas
Activities and honors
Certifications
- 2013
Medical OncologyAmerican Board of Internal Medicine
- 2010
Internal MedicineAmerican Board of Internal Medicine
Awards and honors
- 2010
ChiefClinical Investigator Program, Mayo Graduate School of Medicine, Mayo Clinic College of Medicine and Science
- 2005
Dissertation Defense with HonorsUniversity of Kansas
- 2004
Best Presentation of Graduate, Medical, and Allied Health Schools at KUMCSigma Xi, The Scientific Research Society
- 2004
Best Graduate Student Presentation in the School of MedicineStudent Research Forum, University of Kansas
- 2003
Comprehensive Exam with HonorsDepartment of Pharmacology and Toxicology, University of Kansas
- 1998
Departmental Honors in BiologyUniversity of Kansas
- 1998
Graduation with Distinction (Top 10%)University of Kansas
- 1998
Outstanding Honors Research ThesisUniversity of Kansas
Professional memberships
- 2021 - present
Grant ReviewerThe Austrian Science Fund (FWF)
- 2021 - present
Research Training and Career Enhancement SubcommitteeMayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
- 2021 - present
Ad Hoc ReviewerDepartment of Defense
- 2020
Advisory Board MemberKIYATEC Inc.
- 2020
Advisory Board MemberAstra Zeneca
- 2020
Advisory Board MemberKIYATEC Inc.
- 2019
ConsultantMerek
- 2019 - present
MemberNRG Oncology, Ovarian Committee
- 2019 - present
Assistant DirectorMayo Medical School
- 2019 - present
MemberNRG Oncology Ovarian Cancer Committee
- 2018 - present
Chair, Clinical ResearchDivision of Medical Oncology, Department of Oncology
- 2018
Grant ReviewerBreast Cancer Now
- 2018
Advisory Board MemberKIYATEC Inc.
- 2018 - 2020
Physician RepresentativeWatson Clinical Trial Matching Committee
- 2018 - present
Executive Committee MemberMayo Clinic Ovarian Cancer SPORE
- 2017 - 2019
MemberMayo Medical School
- 2017 - present
Grant ReviewerMayo Clinic Ovarian Cancer SPORE
- 2017 - present
Grant ReviewerFraternal Order of Eagles
- 2016
Grant ReviewerDutch Cancer Society (KWF Kankerbestrijding)
- 2016 - present
Medical Advisory Board - MemberMinnesota Ovarian Cancer Alliance
- 2015 - present
Laboratory DirectorMayo Clinic Ovarian Cancer SPORE
- 2015 - present
MemberDivision of Medical Oncology, Department of Oncology
- 2014 - 2017
Clinical Trials AuditorMayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
- 2013 - 2018
MemberDivision of Medical Oncology, Department of Oncology
- 2013 - present
MemberDivision of Medical Oncology, Department of Oncology
- 2010 - present
MemberAmerican Society of Clinical Oncology
- 2001 - present
MemberAmerican Association for Cancer Research (AACR)
Publications
Research activities